The authors described that a fusion protein of β-glucuronidase with IGF-II, a high-affinity M6PR ligand, improved the targeting to podocytes in Mucopolysacccharidosis VII, another lysosomal disorder, where the podocyte is the most severely-affected kidney cell-type [62]. The gene discussed is M6PR; the disease is lysosomal storage disease.